BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 417024 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cccc(Cl)c1F InChI=1S/C27H23Cl2FN4O2/c1-15(2)33-24-23(16-11-13-17(28)14-12-16)34(20-9-6-8-19(29)22(20)30)27(35)32-25(24)31-26(33)18-7-4-5-10-21(18)36-3/h4-15,23H,1-3H3,(H,32,35) DRUCKCPJGULCLL-UHFFFAOYSA-N 238899 US9403827, 1 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.0 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238899&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 76853605 340132189 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417025 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C28H25Cl2FN4O2/c1-15(2)34-25-24(18-13-12-17(29)14-16(18)3)35(21-10-7-9-20(30)23(21)31)28(36)33-26(25)32-27(34)19-8-5-6-11-22(19)37-4/h5-15,24H,1-4H3,(H,33,36) BRXMLZRLZJJZCH-UHFFFAOYSA-N 238900 US9403827, 2 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2.1 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238900&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303163 340132190 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417026 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C29H28Cl2N4O2/c1-16(2)34-26-25(21-13-12-19(30)14-18(21)4)35(23-15-20(31)11-10-17(23)3)29(36)33-27(26)32-28(34)22-8-6-7-9-24(22)37-5/h6-16,25H,1-5H3,(H,33,36) PHETUTHFDPFIRQ-UHFFFAOYSA-N 238901 US9403827, 3 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1.8 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238901&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303502 340132191 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417027 COc1ccncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C28H27Cl2N5O2/c1-15(2)34-25-24(20-9-8-18(29)12-17(20)4)35(22-13-19(30)7-6-16(22)3)28(36)33-26(25)32-27(34)21-14-31-11-10-23(21)37-5/h6-15,24H,1-5H3,(H,33,36) YMTOKOZHNSRSHG-UHFFFAOYSA-N 238902 US9403827, 4 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3.1 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238902&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303607 340132192 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417028 CC(C)N1C2C(N(C(=O)N=C2N=C1Br)c1cccc(Cl)c1F)c1ccc(Cl)cc1 InChI=1S/C20H16BrCl2FN4O/c1-10(2)27-17-16(11-6-8-12(22)9-7-11)28(14-5-3-4-13(23)15(14)24)20(29)26-18(17)25-19(27)21/h3-10,16-17H,1-2H3 KVODRLANFDRODC-UHFFFAOYSA-N 238903 US9403827, 5 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 120 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238903&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 139267857 340132193 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417029 COc1ccncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cccc(Cl)c1F InChI=1S/C26H22Cl2FN5O2/c1-14(2)33-23-22(15-7-9-16(27)10-8-15)34(19-6-4-5-18(28)21(19)29)26(35)32-24(23)31-25(33)17-13-30-12-11-20(17)36-3/h4-14,22H,1-3H3,(H,32,35) MEIBLGVABAULOU-UHFFFAOYSA-N 238904 US9403827, 6 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 8.5 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238904&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303400 340132194 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417030 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cccc(Cl)c1F InChI=1S/C27H23Cl2FN4O2/c1-15(2)33-24-23(16-11-13-17(28)14-12-16)34(20-9-6-8-19(29)22(20)30)27(35)32-25(24)31-26(33)18-7-4-5-10-21(18)36-3/h4-15,23H,1-3H3,(H,32,35) DRUCKCPJGULCLL-UHFFFAOYSA-N 238899 US9403827, 1 E3 ubiquitin-protein ligase Mdm2 [2-188]/Protein Mdm4 [2-185] Human 1510 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004308&target=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238899&enzyme=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 76853605 340132189 2 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 417031 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C28H25Cl2FN4O2/c1-15(2)34-25-24(18-13-12-17(29)14-16(18)3)35(21-10-7-9-20(30)23(21)31)28(36)33-26(25)32-27(34)19-8-5-6-11-22(19)37-4/h5-15,24H,1-4H3,(H,33,36) BRXMLZRLZJJZCH-UHFFFAOYSA-N 238900 US9403827, 2 E3 ubiquitin-protein ligase Mdm2 [2-188]/Protein Mdm4 [2-185] Human 2130 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004308&target=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238900&enzyme=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90303163 340132190 2 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 417032 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C29H28Cl2N4O2/c1-16(2)34-26-25(21-13-12-19(30)14-18(21)4)35(23-15-20(31)11-10-17(23)3)29(36)33-27(26)32-28(34)22-8-6-7-9-24(22)37-5/h6-16,25H,1-5H3,(H,33,36) PHETUTHFDPFIRQ-UHFFFAOYSA-N 238901 US9403827, 3 E3 ubiquitin-protein ligase Mdm2 [2-188]/Protein Mdm4 [2-185] Human 1450 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004308&target=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238901&enzyme=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90303502 340132191 2 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 417033 COc1ccncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C28H27Cl2N5O2/c1-15(2)34-25-24(20-9-8-18(29)12-17(20)4)35(22-13-19(30)7-6-16(22)3)28(36)33-26(25)32-27(34)21-14-31-11-10-23(21)37-5/h6-15,24H,1-5H3,(H,33,36) YMTOKOZHNSRSHG-UHFFFAOYSA-N 238902 US9403827, 4 E3 ubiquitin-protein ligase Mdm2 [2-188]/Protein Mdm4 [2-185] Human 16690 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004308&target=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238902&enzyme=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90303607 340132192 2 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 417034 COc1ccncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cccc(Cl)c1F InChI=1S/C26H22Cl2FN5O2/c1-14(2)33-23-22(15-7-9-16(27)10-8-15)34(19-6-4-5-18(28)21(19)29)26(35)32-24(23)31-25(33)17-13-30-12-11-20(17)36-3/h4-14,22H,1-3H3,(H,32,35) MEIBLGVABAULOU-UHFFFAOYSA-N 238904 US9403827, 6 E3 ubiquitin-protein ligase Mdm2 [2-188]/Protein Mdm4 [2-185] Human 14040 25.00 C US Patent 10.7270/Q2Z31XKH aid1803194 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004308&target=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238904&enzyme=E3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D%2FProtein+Mdm4+%5B2-185%5D&column=ki&startPg=0&Increment=50&submit=Search 90303400 340132194 2 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 TSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSR 2MWY,2N06,2N0U,2N0W,2N14,2VYR,3DAB,3FDO,3JZO,3JZP,3JZQ,3LBJ,4RXZ,7C3Q,7C3Y,7C44,8HDG,8IA5 Protein Mdm4 MDM4_HUMAN O15151 Q2M2Y2 Q32SL2 Q6GS18 Q8IV83 417035 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cccc(Cl)c1F InChI=1S/C27H23Cl2FN4O2/c1-15(2)33-24-23(16-11-13-17(28)14-12-16)34(20-9-6-8-19(29)22(20)30)27(35)32-25(24)31-26(33)18-7-4-5-10-21(18)36-3/h4-15,23H,1-3H3,(H,32,35) DRUCKCPJGULCLL-UHFFFAOYSA-N 238899 US9403827, 1 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 882 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238899&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 76853605 340132189 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417036 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cccc(Cl)c1F InChI=1S/C28H25Cl2FN4O2/c1-15(2)34-25-24(18-13-12-17(29)14-16(18)3)35(21-10-7-9-20(30)23(21)31)28(36)33-26(25)32-27(34)19-8-5-6-11-22(19)37-4/h5-15,24H,1-4H3,(H,33,36) BRXMLZRLZJJZCH-UHFFFAOYSA-N 238900 US9403827, 2 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 779 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238900&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303163 340132190 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417037 COc1ccc(F)cc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C29H27Cl2FN4O2/c1-15(2)35-26-25(21-10-8-18(30)12-17(21)4)36(23-13-19(31)7-6-16(23)3)29(37)34-27(26)33-28(35)22-14-20(32)9-11-24(22)38-5/h6-15,25H,1-5H3,(H,34,37) ZGQNMNAEHZBLAU-UHFFFAOYSA-N 238905 US9403827, 7 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 531 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238905&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303340 340132195 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417038 COc1ccc(cc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C)C(=O)NCCO InChI=1S/C32H33Cl2N5O4/c1-17(2)38-28-27(23-10-9-21(33)14-19(23)4)39(25-16-22(34)8-6-18(25)3)32(42)37-29(28)36-30(38)24-15-20(7-11-26(24)43-5)31(41)35-12-13-40/h6-11,14-17,27,40H,12-13H2,1-5H3,(H,35,41)(H,37,42) VPFHEGRIBFSFST-UHFFFAOYSA-N 238906 US9403827, 8 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 447 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238906&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303398 340132196 C04080 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417039 CNC(=O)c1ccc(OC)c(c1)-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C31H31Cl2N5O3/c1-16(2)37-27-26(22-11-10-20(32)13-18(22)4)38(24-15-21(33)9-7-17(24)3)31(40)36-28(27)35-29(37)23-14-19(30(39)34-5)8-12-25(23)41-6/h7-16,26H,1-6H3,(H,34,39)(H,36,40) UKQCXTLDQPXSOF-UHFFFAOYSA-N 238907 US9403827, 9 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 210 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238907&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303291 340132197 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417040 COc1ccc(cc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C)C(=O)N(C)C InChI=1S/C32H33Cl2N5O3/c1-17(2)38-28-27(23-12-11-21(33)14-19(23)4)39(25-16-22(34)10-8-18(25)3)32(41)36-29(28)35-30(38)24-15-20(31(40)37(5)6)9-13-26(24)42-7/h8-17,27H,1-7H3,(H,36,41) AJIVOSOKWBCTKY-UHFFFAOYSA-N 238908 US9403827, 10 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 432 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238908&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303499 340132198 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417041 COc1ccc(CO)cc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C InChI=1S/C30H30Cl2N4O3/c1-16(2)35-27-26(22-10-9-20(31)12-18(22)4)36(24-14-21(32)8-6-17(24)3)30(38)34-28(27)33-29(35)23-13-19(15-37)7-11-25(23)39-5/h6-14,16,26,37H,15H2,1-5H3,(H,34,38) ZCELMKLYXSRUEB-UHFFFAOYSA-N 238909 US9403827, 11 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 371 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238909&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303525 340132199 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417042 COc1ccc(cc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1C)c1cc(Cl)ccc1C)C#N InChI=1S/C30H27Cl2N5O2/c1-16(2)36-27-26(22-10-9-20(31)12-18(22)4)37(24-14-21(32)8-6-17(24)3)30(38)35-28(27)34-29(36)23-13-19(15-33)7-11-25(23)39-5/h6-14,16,26H,1-5H3,(H,35,38) FBAYKMBCSLPEOY-UHFFFAOYSA-N 238910 US9403827, 12 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 414 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238910&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303356 340132200 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417043 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cc(Cl)ccc1C InChI=1S/C29H26ClN5O2/c1-17(2)34-26-25(20-12-10-19(16-31)11-13-20)35(23-15-21(30)14-9-18(23)3)29(36)33-27(26)32-28(34)22-7-5-6-8-24(22)37-4/h5-15,17,25H,1-4H3,(H,33,36) OUWACAFRBJFKML-UHFFFAOYSA-N 238911 US9403827, 13 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 724 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238911&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303394 340132201 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417044 COc1ccccc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(cc1)C#N)c1cccc(Cl)c1F InChI=1S/C28H23ClFN5O2/c1-16(2)34-25-24(18-13-11-17(15-31)12-14-18)35(21-9-6-8-20(29)23(21)30)28(36)33-26(25)32-27(34)19-7-4-5-10-22(19)37-3/h4-14,16,24H,1-3H3,(H,33,36) JTWGDBFVJKVIPZ-UHFFFAOYSA-N 238912 US9403827, 14 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 473 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238912&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303590 340132202 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417045 COc1ncc(-c2nc3NC(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2ccc(F)c(Cl)c2)c(OC)n1 InChI=1S/C26H22Cl2F2N6O3/c1-12(2)35-21-20(13-5-7-16(27)19(30)9-13)36(14-6-8-18(29)17(28)10-14)26(37)33-22(21)32-23(35)15-11-31-25(39-4)34-24(15)38-3/h5-12,20H,1-4H3,(H,33,37) YGQRCKOQIJBCSF-UHFFFAOYSA-N 238913 US9403827, 15 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 451 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238913&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303284 340132203 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417046 COc1ncc(-c2nc3NC(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2C)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C27H27Cl2N7O4/c1-13(2)35-21-20(17-8-7-15(28)9-14(17)3)36(16-10-19(29)25(37)34(4)12-16)27(38)32-22(21)31-23(35)18-11-30-26(40-6)33-24(18)39-5/h7-13,20H,1-6H3,(H,32,38) IQLOHRMQNATWKF-UHFFFAOYSA-N 238914 US9403827, 16 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 3106 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238914&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90304487 340132204 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417047 COc1ncc(-c2nc3NC(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C26H24Cl2FN7O4/c1-12(2)35-20-19(13-6-7-16(28)17(29)8-13)36(18-9-14(27)11-34(3)24(18)37)26(38)32-21(20)31-22(35)15-10-30-25(40-5)33-23(15)39-4/h6-12,19H,1-5H3,(H,32,38) VGLYFXQLTJMDQM-UHFFFAOYSA-N 238915 US9403827, 17 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 1668 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238915&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303931 340132205 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417048 COc1ncc(-c2nc3NC(=O)N(C(c3n2C(C)C)c2ccc(Cl)cc2)c2cc(Cl)cn(C)c2=O)c(OC)n1 InChI=1S/C26H25Cl2N7O4/c1-13(2)34-20-19(14-6-8-15(27)9-7-14)35(18-10-16(28)12-33(3)24(18)36)26(37)31-21(20)30-22(34)17-11-29-25(39-5)32-23(17)38-4/h6-13,19H,1-5H3,(H,31,37) ZIJQAFGQDANOSU-UHFFFAOYSA-N 238916 US9403827, 18 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 2914 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238916&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303348 340132206 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417049 COc1ncc(-c2nc3NC(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2cc(Cl)c(=O)n(C)c2)c(OC)n1 InChI=1S/C26H24Cl2FN7O4/c1-12(2)35-20-19(13-6-7-16(27)18(29)8-13)36(14-9-17(28)24(37)34(3)11-14)26(38)32-21(20)31-22(35)15-10-30-25(40-5)33-23(15)39-4/h6-12,19H,1-5H3,(H,32,38) GXKSSHSTHPQWCM-UHFFFAOYSA-N 238917 US9403827, 19 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 930 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238917&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303238 340132207 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417050 COc1nc(ncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)c[nH]c1=O)N(C)C 238918 US9403827, 20 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 354 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238918&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012625 340132208 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417051 COc1nc(N)ncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)cn(C)c1=O InChI=1S/C25H24Cl2N8O3/c1-12(2)34-19-18(13-5-7-14(26)8-6-13)35(17-9-15(27)11-33(3)23(17)36)25(37)31-20(19)30-21(34)16-10-29-24(28)32-22(16)38-4/h5-12,18H,1-4H3,(H,31,37)(H2,28,29,32) YTWAIYKATIMZBH-UHFFFAOYSA-N 238919 US9403827, 21 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 4298 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238919&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303393 340132209 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417052 COc1nc(ncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)cc1)c1cc(Cl)cn(C)c1=O)N(C)C InChI=1S/C27H28Cl2N8O3/c1-14(2)36-21-20(15-7-9-16(28)10-8-15)37(19-11-17(29)13-35(5)25(19)38)27(39)32-22(21)31-23(36)18-12-30-26(34(3)4)33-24(18)40-6/h7-14,20H,1-6H3,(H,32,39) UFHJUOJFZGVQSM-UHFFFAOYSA-N 238920 US9403827, 22 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 587 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238920&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303341 340132210 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417053 COc1nc(ncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)c(F)c1)c1ccc(F)c(Cl)c1)N(C)C InChI=1S/C27H25Cl2F2N7O2/c1-13(2)37-22-21(14-6-8-17(28)20(31)10-14)38(15-7-9-19(30)18(29)11-15)27(39)34-23(22)33-24(37)16-12-32-26(36(3)4)35-25(16)40-5/h6-13,21H,1-5H3,(H,34,39) WHHGNSYEEPQONV-UHFFFAOYSA-N 238921 US9403827, 23 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 385 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238921&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90303476 340132211 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417054 COc1nc(ncc1-c1nc2NC(=O)N(C(c2n1C(C)C)c1ccc(Cl)c(F)c1)c1cc(Cl)cn(C)c1=O)N(C)C InChI=1S/C27H27Cl2FN8O3/c1-13(2)37-21-20(14-7-8-17(29)18(30)9-14)38(19-10-15(28)12-36(5)25(19)39)27(40)33-22(21)32-23(37)16-11-31-26(35(3)4)34-24(16)41-6/h7-13,20H,1-6H3,(H,33,40) NHTLDXGQQBCRLF-UHFFFAOYSA-N 238922 US9403827, 24 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 748 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238922&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 90317045 340132212 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8 417055 COc1ncc(-c2nc3NC(=O)N(C(c3n2C(C)C)c2ccc(Cl)c(F)c2)c2cc(Cl)c[nH]c2=O)c(OC)n1 238923 US9403827, 25 Cellular tumor antigen p53 [18-26]/E3 ubiquitin-protein ligase Mdm2 [2-188] Human 356 25.00 C US Patent 10.7270/Q2Z31XKH aid1803195 US9403827 Furet, P; Guagnano, V; Holzer, P; Kallen, J; Mah, R; Masuya, K; Schlapbach, A; Vaupel, A 8/2/2016 7/24/2017 Novartis AG http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=238923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=com&complexid=50004102&target=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=238923&enzyme=Cellular+tumor+antigen+p53+%5B18-26%5D%2FE3+ubiquitin-protein+ligase+Mdm2+%5B2-188%5D&column=ki&startPg=0&Increment=50&submit=Search 129012626 340132213 2 TFSDLWKLL Cellular tumor antigen p53 P53_HUMAN P04637 Q15086 Q15087 Q15088 Q16535 Q16807 Q16808 Q16809 Q16810 Q16811 Q16848 Q2XN98 Q3LRW1 Q3LRW2 Q3LRW3 Q3LRW4 Q3LRW5 Q86UG1 Q8J016 Q99659 Q9BTM4 Q9HAQ8 Q9NP68 Q9NPJ2 Q9NZD0 Q9UBI2 Q9UQ61 CNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDS 1T4E,1T4F,1YCR,1Z1M,2GV2,2LZG,2M86,2MPS,3EQS,3G03,3IUX,3IWY,3JZK,3JZR,3JZS,3LBL,3LNJ,3LNZ,3TJ2,3TPX,3TU1,3V3B,4ERE,4ERF,4HBM,4JV7,4JV9,4JVE,4JVR,4JWR,4MDN,4MDQ,4OAS,4OBA,4OCC,4ODE,4ODF,4OGN,4OGT,4OGV,4QO4,4QOC,4WT2,4ZFI,4ZGK,4ZYF,4ZYI,5C5A,5J7F,5J7G,5LAV,5LAW,5LAY,5LAZ,5LN2,5OAI,5OC8,5SWK,5TRF,5UMM,5VK0,5WTS,5Z02,5ZXF,6AAW,6GGN,6I29,6I3S,6IM9,6KZU,6Q96,6Q9H,6Q9L,6Q9O,7AD0,7AYE,7KJM,7NA2,7NA3,7NA4,7NUS,7QDQ,8AEU,8F0Z,8F10,8F12,8F13 E3 ubiquitin-protein ligase Mdm2 MDM2_HUMAN Q00987 A6NL51 A8K2S6 Q13226 Q13297 Q13298 Q13299 Q13300 Q13301 Q53XW0 Q71TW9 Q8WYJ1 Q8WYJ2 Q9UGI3 Q9UMT8